Shilpa Medicare is a manufacturer of API, formulation, and development services. Shilpa Medicare (SML) started its operations ...

Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health ...

Shilpa Medicare's facility in Bengaluru is capable of manufacturing, packaging, testing, storage and distribution of two ...

Karnataka: Shilpa Medicare Limited has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI ...

The company, in an exchange filing on July 16, said that Unit VI, Dabaspet, Bengaluru, Karnataka, India, has received an EIR with VAI (Voluntary Action Indicated) classification from the US FDA.

Shilpa Medicare shares zoomed over 4% after the company announced that it has received an Establishment Inspection Report (EIR) for the Bengaluru unit from the USFDA. At around 2.06 PM, Shilpa ...

Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI ...

The certification follows an on-site inspection conducted from 18 February to 20 February 2025. It was a full GMP inspection ...

Karnataka: Shilpa Medicare has announced that its Unit VI facility, located at Dabaspet, Bengaluru, Karnataka, has received ...

In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship product, sRbumin ...

RAICHUR, India, Aug. 28, 2024 /PRNewswire/ -- In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical ...

Shilpa Medicare Limited Logo. The Phase 1 clinical study was a randomized, dose-escalating, comparative trial against European-sourced human-derived serum albumin, involving 62 healthy volunteers.